Sanofi (SNY)
(Delayed Data from NSDQ)
$46.30 USD
+0.91 (2.00%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $46.32 +0.02 (0.04%) 7:12 PM ET
4-Sell of 5 4
A Value B Growth F Momentum A VGM
Sanofi (SNY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$60.90 | $67.00 | $55.00 | 34.17% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Sanofi comes to $60.90. The forecasts range from a low of $55.00 to a high of $67.00. The average price target represents an increase of 34.17% from the last closing price of $45.39.
Analyst Price Targets (5 )
Broker Rating
Sanofi currently has an average brokerage recommendation (ABR) of 1.86 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 1.86 a month ago based on 14 recommendations.
Of the 14 recommendations deriving the current ABR, nine are Strong Buy, representing 64.29% of all recommendations. A month ago, Strong Buy represented 64.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 8 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.86 | 1.86 | 1.86 | 1.83 | 1.83 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/8/2024 | Argus Research Corp. | Jasper Hellweg | Strong Buy | Strong Buy |
2/5/2024 | SVB Securities | David Risinger | Strong Buy | Strong Buy |
9/5/2023 | Berenberg Bank | Luisa Hector | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.86 |
ABR (Last week) | 1.86 |
# of Recs in ABR | 14 |
Average Target Price | $60.90 |
LT Growth Rate | 6.90% |
Industry | Large Cap Pharmaceuticals |
Industry Rank by ABR | 195 of 252 |
Current Quarter EPS Est: | 0.97 |